Anu Airaksinen
Anu Airaksinen
Associate Professor, Radiopharmaceutical Chemistry, Turku PET Centre/University of Turku, Finland
E-mail confirmado em utu.fi - Página inicial
Título
Citado por
Citado por
Ano
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ...
ACS nano 4 (6), 3023-3032, 2010
3082010
Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
HA Santos, E Mäkilä, AJ Airaksinen, LM Bimbo, J Hirvonen
Nanomedicine 9 (4), 535-554, 2014
1382014
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution
M Sarparanta, LM Bimbo, J Rytkönen, E Mäkilä, TJ Laaksonen, ...
Molecular Pharmaceutics 9 (3), 654-663, 2012
1322012
Multifunctional porous silicon nanoparticles for cancer theranostics
CF Wang, MP Sarparanta, EM Mäkilä, MLK Hyvönen, PM Laakkonen, ...
Biomaterials 48, 108-118, 2015
1212015
The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
MP Sarparanta, LM Bimbo, EM Mäkilä, JJ Salonen, PH Laaksonen, ...
Biomaterials 33 (11), 3353-3362, 2012
1122012
Amine modification of thermally carbonized porous silicon with silane coupling chemistry
E Mäkilä, LM Bimbo, M Kaasalainen, B Herranz, AJ Airaksinen, ...
Langmuir 28 (39), 14045-14054, 2012
972012
Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
CF Wang, EM Mäkilä, MH Kaasalainen, D Liu, MP Sarparanta, ...
Biomaterials 35 (4), 1257-1266, 2014
932014
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
N Seneca, B Gulyás, A Varrone, M Schou, A Airaksinen, J Tauscher, ...
Psychopharmacology 188 (1), 119-127, 2006
892006
18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
M Sarparanta, E Mäkilä, T Heikkilä, J Salonen, E Kukk, VP Lehto, ...
Molecular pharmaceutics 8 (5), 1799-1806, 2011
772011
Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [11C] vinpocetine
B Gulyás, M Tóth, M Schain, A Airaksinen, Á Vas, K Kostulas, P Lindström, ...
Journal of the neurological sciences 320 (1-2), 110-117, 2012
722012
[18F] Flumazenil binding to central benzodiazepine receptor studies by PET:–Quantitative analysis and comparisons with [11C] flumazenil–
I Odano, C Halldin, P Karlsson, A Varrone, AJ Airaksinen, RN Krasikova, ...
Neuroimage 45 (3), 891-902, 2009
712009
SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications
C Nilsson, B Barrios-Lopez, A Kallinen, P Laurinmäki, SJ Butcher, M Raki, ...
Biomaterials 34 (33), 8491-8503, 2013
642013
Cellular interactions of surface modified nanoporous silicon particles
LM Bimbo, M Sarparanta, E Mäkilä, T Laaksonen, P Laaksonen, ...
Nanoscale 4 (10), 3184-3192, 2012
572012
In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
MPA Ferreira, S Ranjan, AMR Correia, EM Mäkilä, SM Kinnunen, ...
Biomaterials 94, 93-104, 2016
532016
Adenovirus improves the efficacy of adoptive T-cell therapy by recruiting immune cells to and promoting their activity at the tumor
S Tähtinen, S Grönberg-Vähä-Koskela, D Lumen, M Merisalo-Soikkeli, ...
Cancer immunology research 3 (8), 915-925, 2015
472015
Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter
T Hakkarainen, M Rajecki, M Sarparanta, M Tenhunen, AJ Airaksinen, ...
Clinical Cancer Research 15 (17), 5396-5403, 2009
462009
Drug‐loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic Signaling
MPA Ferreira, S Ranjan, S Kinnunen, A Correia, V Talman, E Mäkilä, ...
Small 13 (33), 1701276, 2017
442017
Pretargeting of internalizing trastuzumab and cetuximab with a 18 F-tetrazine tracer in xenograft models
O Keinänen, K Fung, J Pourat, V Jallinoja, D Vivier, NVK Pillarsetty, ...
EJNMMI research 7 (1), 1-12, 2017
372017
Synthesis, in vitro and in vivo evaluation of 1, 3, 5-triazines as cannabinoid CB2 receptor agonists
S Yrjölä, M Sarparanta, AJ Airaksinen, M Hytti, A Kauppinen, ...
European Journal of Pharmaceutical Sciences 67, 85-96, 2015
372015
A new highly reactive and low lipophilicity fluorine-18 labeled tetrazine derivative for pretargeted PET imaging
O Keinänen, XG Li, NK Chenna, D Lumen, J Ott, CFM Molthoff, ...
ACS medicinal chemistry letters 7 (1), 62-66, 2016
362016
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20